Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity

Journal of Neurochemistry
Mieke de JagerMicha M M Wilhelmus


Cerebral amyloid angiopathy (CAA) is a pathological hallmark of Alzheimer's disease (AD) and characterized by deposition of amyloid-β (Aβ) protein and smooth muscle cell (SMC) death in cerebral vessel walls. Apolipoprotein E (ApoE) is of importance in both Aβ accumulation and Aβ-mediated toxicity towards SMCs in the cerebral vessel wall, although its exact role in CAA pathogenesis remains unclear. Tissue transglutaminase (tTG) is an enzyme capable of inducing both protein complexes and altered protein bioactivity via post-translational cross-linking. In CAA, tTG and its catalytic activity are associated with deposited Aβ. Furthermore, several apolipoproteins are known substrates of tTG. We therefore investigated whether ApoE is a substrate for tTG and if this affects ApoE's bioactivity. We found strong binding of different ApoE isoforms with tTG and demonstrated tTG-catalysed ApoE multimers. In post-mortem human AD cases, ApoE colocalized with in situ active tTG in CAA. Moreover, human brain SMCs treated with Aβ demonstrated enhanced secretion of both ApoE and tTG, and of TG cross-links in the extracellular matrix. Interestingly, tTG-catalysed cross-linked ApoE failed to protect SMCs against Aβ-mediated cytotoxicity. Together, ...Continue Reading


Jan 1, 1977·Advances in Protein Chemistry·J C Osborne, H B Brewer
Sep 1, 1977·Biopolymers·J P Segrest, R J Feldmann
Apr 1, 1991·Neuron·D J Selkoe
Feb 1, 1990·The Biochemical Journal·E CocuzziS I Chung
Jan 1, 1984·Molecular and Cellular Biochemistry·Laszlo Lorand, S M Conrad
May 11, 1984·Nucleic Acids Research·C R SharpeF E Baralle
Apr 15, 1983·Biochemical and Biophysical Research Communications·S W LawH B Brewer
Feb 28, 1994·Biochemical and Biophysical Research Communications·J S WhitsonS H Appel
Sep 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·W J StrittmatterA D Roses
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·D E SchmechelA D Roses
Dec 1, 1996·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·D M AppeltB J Balin
Mar 21, 1997·Brain Research·G V JohnsonR E Powers
Jun 6, 2002·European Biophysics Journal : EBJ·Danny M Hatters, Geoffrey J Howlett
Oct 9, 2002·Trends in Biochemical Sciences·Laszlo Fesus, Mauro Piacentini
Feb 4, 2003·Nature Reviews. Molecular Cell Biology·Laszlo Lorand, Robert M Graham
Apr 9, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Micha M M WilhelmusMarcel M Verbeek
Apr 8, 2006·Neuropathology and Applied Neurobiology·Micha M M WilhelmusMarcel M Verbeek
May 25, 2006·The Protein Journal·Joseph J WakshlagRichard A Cerione
Aug 8, 2006·Journal of Molecular Biology·Danny M HattersKarl H Weisgraber
Dec 7, 2007·The American Journal of Pathology·Micha M M WilhelmusMarcel M Verbeek
Mar 13, 2008·Journal of Alzheimer's Disease : JAD·Deng-Shun WangDennis W Dickson
Apr 18, 2008·European Journal of Pharmacology·Micha M M WilhelmusBenjamin Drukarch
May 29, 2008·Protein Science : a Publication of the Protein Society·Ine M J Segers-NoltenVinod Subramaniam
Nov 20, 2008·Journal of Lipid Research·Godfrey S Getz, Catherine A Reardon
Dec 10, 2008·Stroke; a Journal of Cerebral Circulation·Gregory J ZipfelJin-Moo Lee
Mar 26, 2009·Analytical Biochemistry·Mileidys Perez AleaSaïd El Alaoui
Apr 17, 2010·Journal of Biomolecular Screening·Sabine SchaertlDouglas Macdonald
Oct 16, 2010·Neuropathology and Applied Neurobiology·J AttemsW Van Nostrand
Mar 23, 2011·Cold Spring Harbor Perspectives in Biology·Peter D Yurchenco
Jan 24, 2012·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Bradley T HymanThomas J Montine
Mar 7, 2012·Cold Spring Harbor Perspectives in Medicine·David M HoltzmanGuojun Bu
Nov 6, 2012·Neurobiology of Aging·Mieke de JagerMicha M M Wilhelmus


Apr 14, 2016·Nuclear Medicine and Biology·Berend van der WildtAlbert D Windhorst
Oct 13, 2017·International Journal of Molecular Sciences·Ciro De LucaMichele Papa
Jul 29, 2018·Bioscience Reports·Thomas M JeitnerArthur J L Cooper
Nov 22, 2018·Brain : a Journal of Neurology·Ananya ChakrabortyHelga E de Vries
Dec 12, 2018·Frontiers in Cellular Neuroscience·Ciro De LucaMichele Papa

Related Concepts

Alzheimer's Disease
Apolipoprotein E
Blood Vessel
Cessation of Life
Extracellular Matrix
Hyperlipoproteinemia Type III

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.